BMJ Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2023-06-01 ms1000001196939121 来自安徽省

已经投了三个月了，还在找审稿人，咋办呀?真的好难

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2022-11-08 ms7000000998286852

我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2023-06-06 TXTY 来自河南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：meta分析
经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2023-06-02 ms6000001743293475 来自安徽省

请问可以共通讯吗？

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2023-05-22 ms1000001381501263 来自云南省

请问大家投稿时有遇到Licence Statement A is a required field的问题吗

32 0

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2023-05-01 ms3000001735198901 来自四川省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：乳腺癌;protocal
经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗

38 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2022-11-24 小胖达0110 来自四川省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：循证医学
经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision

67 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2017-08-01 BMJ中国

大家好！感谢大家对于BMJ Open的关注！
如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。
谢谢！

306 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2023-02-23 Eugence 来自北京

审稿速度:6.0
经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。

56 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140387, encodeId=0411214038ee8, content=已经投了三个月了，还在找审稿人，咋办呀?真的好难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1978669291, createdName=ms1000001196939121, createdTime=Thu Jun 01 23:12:31 CST 2023, time=2023-06-01, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2099163, encodeId=ad7a20991632e, content=我一篇meta投了BMJ OPEN, 10.21更新状态 awaiting ME decision，现在又变成了Awaiting Reviewer Selection，请问有遇到过这种情况的吗？之后大家结果都怎么样了呀？一般能修回的概率多大呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3045680465, createdName=ms7000000998286852, createdTime=Tue Nov 08 13:23:44 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2141028, encodeId=37502141028f4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：meta分析 经验分享：请问大家，submitted之后多久进入下一个状态？如果退稿会不会很快？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a691625071, createdName=TXTY, createdTime=Tue Jun 06 09:14:55 CST 2023, time=2023-06-06, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140467, encodeId=2abc214046ec2, content=请问可以共通讯吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7d8628212, createdName=ms6000001743293475, createdTime=Fri Jun 02 13:45:31 CST 2023, time=2023-06-02, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2138446, encodeId=af8b2138446a0, content=请问大家投稿时有遇到Licence Statement A is a required field的问题吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9718352795, createdName=ms1000001381501263, createdTime=Mon May 22 20:49:14 CST 2023, time=2023-05-22, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2129524, encodeId=85cb2129524c2, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：乳腺癌;protocal 经验分享：提交了快一个月了，今天还是提交状态，请问是正常的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6af45624822, createdName=ms3000001735198901, createdTime=Mon May 01 09:59:19 CST 2023, time=2023-05-01, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2102452, encodeId=1e532102452bc, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：循证医学 经验分享：投的meta 的 protocol ，10-6号投的，11-21号变为awaiting me decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16dc2487292, createdName=小胖达0110, createdTime=Thu Nov 24 17:44:54 CST 2022, time=2022-11-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=544984, encodeId=fa2b54498401, content=大家好！感谢大家对于BMJ Open的关注！ 如果有对于投稿BMJ Open的任何问题和建议，请关注BMJ官方微信公众号 BMJChina，在首页留言，并留下您的邮箱，BMJ中国团队将尽快为您回复解答。 谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3cb71944510, createdName=BMJ中国, createdTime=Tue Aug 01 11:12:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116123, encodeId=dd342116123b9, content=审稿速度:6.0 经验分享：目前还在等待审稿，距我投稿已经半年了，中间好几次让我给他们推荐审稿人，着审稿人都没找着，已经半年了，我的天，这啥时候才是个头啊，都快毕业了都。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=00585585886, createdName=Eugence, createdTime=Thu Feb 23 15:15:57 CST 2023, time=2023-02-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2104218, encodeId=ffea2104218d5, content=偏重的研究方向：Protocol(RCT类型) 经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b55641569, createdName=ms4000001463952967, createdTime=Sun Dec 04 10:20:37 CST 2022, time=2022-12-04, status=1, ipAttribution=四川省)]

2022-12-04 ms4000001463952967 来自四川省

偏重的研究方向：Protocol(RCT类型)
经验分享：二月底投稿的，之后一直没有消息，在 reviewer selection 和reply之间循环，七月底收到大修，一个月后返回，10月中旬收到小修，一个月后返回，12月1号接收，历史十个月左右，除了慢点，这个杂志的编辑和审稿人都挺不错，不着急的可以投

64 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务